يعرض 1 - 20 نتائج من 71 نتيجة بحث عن '"O. A. Soldatova"', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المصدر: Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 0, Iss 5, Pp 91-101 (2021)

    وصف الملف: electronic resource

  4. 4
    Academic Journal

    المساهمون: The authors declare no funding for this study, Авторы заявляют об отсутствии финансирования при проведении исследования

    المصدر: The Russian Archives of Internal Medicine; Том 14, № 3 (2024); 221-227 ; Архивъ внутренней медицины; Том 14, № 3 (2024); 221-227 ; 2411-6564 ; 2226-6704

    وصف الملف: application/pdf

    Relation: https://www.medarhive.ru/jour/article/view/1799/1325; Shu H., Zhao Ch., Wang D. Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies. Cardiol Plus. 2023; 8(2): 72–81. doi:10.1097/CP9.0000000000000046; Torre-Amione G., Kapadia S., Lee J. et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996; 93: 704-11. doi:10.1161/01.cir.93.4.704; Oudit G. Y., Kassiri Z., Jiang C. et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009; 39: 618-25. doi:10.1111/j.1365-2362.2009.02153.x; Inciardi R. M., Lupi L., Zaccone G. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1; 5(7):819-824. doi:10.1001/jamacardio.2020.1096; Tang N., Li D., Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 8447. doi:10.1111/jth.14768; Driggin E., Madhavan M. V., Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020; 75(18): 2352–2371. doi:10.1016/J.JACC.2020.03.031; Castiello T., Georgiopoulos G., Finocchiaro G. et al. COVID-19 and myocarditis : a systematic review and overview of current challenges. Heart Failure Reviews. 2022; 27(1): 251-261. doi:10.1007/s10741-021-10087-9.; Gessler N., Gunawardene M. A., Wohlmuth P. et al. Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients-Results from the CORONA Germany study. PLoS One. 2021. 17; 16(6): e0252867. doi:10.1371/journal.pone.0252867; Aghagoli G., Gallo Marin B., Soliman L. B., Sellke F. W. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications : A review. J. Card. Surg. 2020. 35(6): 1302–1305. doi:10.1111/jocs.14538.; Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-848. doi:10.1007/s00134-020-05991-x; Pirzada A., Mokhtar A. T., Moeller A. D. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open.2020; 2(4): 278–285. doi:10.1016/J.CJCO.2020.05.005.; Gao, L., Jiang, D., Wen X. et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Gao et al. Respiratory Research. 2020; 21: 83. doi:10.1186/s12931-020-01352-w; Akhmerov A., Marban E. COVID-19 and the Heart. Circulation. 2020.8; 126(10): 1443-1455. doi:10.1161/CIRCRESAHA.120.317055; Aras D., Tufekcioglu O., Ergun K. et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J. Card. Fail. 2006; 12(9): 726-733. doi:10.1016/j.cardfail.2006.08.002; Engberding R., Yelbuz T. M., Breithardt G. Isolated noncompaction of the left ventricular myocardium — a review of the literature two decades after the initial case description. Clin Res Cardiol. 2007; 96(7): 481– 488. doi:10.1007/s00392-007-0528-6.; Long B., Brady W. J., Koyfman A. et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020; 38(7): 1504-1507. doi:10.1016/j.ajem.2020.04.048; Practice of echocardiography during the COVID-19 pandemic: guidance from the Canadian Society of Echocardiography [Electronic resource]. URL: http://csecho.ca/wp-content/uploads/2020/03/CSE-COVID-19-Guidance_English-1.pdf (access date: 15. 10. 2021).; https://www.medarhive.ru/jour/article/view/1799

  5. 5
    Academic Journal

    المصدر: Bulletin of Siberian Medicine; Том 22, № 2 (2023); 165-169 ; Бюллетень сибирской медицины; Том 22, № 2 (2023); 165-169 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2023-22-2

    وصف الملف: application/pdf

    Relation: https://bulletin.ssmu.ru/jour/article/view/5233/3405; https://bulletin.ssmu.ru/jour/article/view/5233/3428; Багманова З.А. Аномалии коронарных артерий. Кардиология. 2010;8:48–55.; Ghanim D., Kusniec F., Kinany W., Qarawani D., Meerkin D., Taha K. et al. Left circumflex coronary artery as the culprit vessel in st-segment-elevation myocardial infarction. Texas Heart Institute Journal. 2017;44(5):320–325. DOI:10.14503/THIJ16-5905.; Lanjewar C.P., Kumar D., Sabnis G.R., Jare M., Phutane M., Shah H. et al. Anomalous origin of coronary artery from the opposite aortic sinus of Valsalva-a single center experience with a therapeutic conundrum. Indian Heart Journal. 2021;73(3):289–294. DOI:10.1016/j.ihj.2021.03.012.; McCord C. Surgical treatment of coronary arteriosclerosis. JAMA. 1971;16(10):1650. DOI:10.1001/jama.1971.03180360096030.; Seok O., Ju H.K., Min C.K., Young J.H., Youngkeun A., Myung H.J. Posterior myocardial infarction caused by superdominant circumflex occlusion over an absent right coronary artery: Case report and review of literature. MD Journal. 2021;100(27):e26604. DOI:10.1097/MD.0000000000026604.; Yan G.W., Bhetuwal A., Yang G.Q., Fu Q.S., Hu N., Zhao L.W. et al. Congenital absence of the right coronary artery: A case report and literature review. Medicine (Baltimore). 2018;97(12):e0187. DOI:10.1097/MD.0000000000010187.; Tomanek R., Angelini P. Embryology of coronary arteries and anatomy/pathophysiology of coronary anomalies. A comprehensive Update. International Journal of Cardiology. 2019;281:28–34. DOI:10.1016/j.ijcard.2018.11.135.; Harky A., Hof A., Ahmad M.U., Uppal R. Incidental finding of anomalous circumflex coronary artery from right coronary sinus prior to aortic valve surgery. BMJ Case Reports. 2017;2017:bcr2017219265. DOI:10.1136/bcr-2017-219265.; Rosseel L., Bonnier H., Sonck J. Anomalous right coronary artery in a middle-aged patient: a case report and review of the literature. Medicine (Baltimore). 2016;95(49):e5508. DOI:10.1097/MD.0000000000005508.; Botta L., Amodio C., Pagano V., Di Marco L., Leone A., Loforte A. et al. AVR in patients with anomalous course of the circumflex artery without prosthetic downsizing. Journal of Cardiac Surgery. 2020;35(11):125–3127. DOI:10.1111/jocs.14927.; Gasparovic I., Artemiou P., Kiss M., Hulman M. Bentall operation in a patient with an anomalous left circumflex artery: case report and review. Journal of Saudi Heart Association. 2017;29(4):305–307. DOI:10.1016/j.jsha.2017.03.003.; Tabachnick D., Obokhae B., Harrington K., Brown D.L. Assessing the risk of an anomalous circumflex artery using balloon aortic valvuloplasty prior to transcatheter aortic valve replacement. Catheter Cardiovascular Intervention. 2020;96(2):497–499. DOI:10.1002/ccd.28695.; https://bulletin.ssmu.ru/jour/article/view/5233

  6. 6
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المؤلفون: O S Soldatova

    المصدر: Polylinguality and Transcultural Practices, Vol 0, Iss 5, Pp 102-107 (2008)

    مصطلحات موضوعية: Philology. Linguistics, P1-1091

    وصف الملف: electronic resource

  14. 14
    Academic Journal
  15. 15
  16. 16
    Academic Journal

    المصدر: Current Pediatrics; Том 14, № 5 (2015); 579-585 ; Вопросы современной педиатрии; Том 14, № 5 (2015); 579-585 ; 1682-5535 ; 1682-5527

    وصف الملف: application/pdf

    Relation: https://vsp.spr-journal.ru/jour/article/view/1513/551; Kahn P. Juvenile idiopathic arthritis: an update for the clinician. Bull NYU Hosp Jt Dis. 2012; 70 (3): 152–166.; Баранов А. А., Алексеева Е. И. Ювенильный артрит: клинические рекомендации для педиатров. Детская ревматология. М.: ПедиатрЪ. 2013. 120 с.; Gurion R. R., Lehman T. J. A., Moorthy L. N. Systemic arthritis in children: a review of clinical presentation and treatment. Int. J. Inflam. 2012; Article ID 271569-16.; Woerner A., von Scheven-Gete A., Cimaz R., Hofer M. Complica tions of systemic juvenile idiopathic arthritis: risk factors and management recommendations. Exp. Rev. Clin. Immunol. 2015; 11 (5): 575–588.; Mellins E. D., MacAubas A., Grom A. A. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat. Rev. Rheum. 2011; 7 (7): 416–426.; Sikora K. A., Grom A. A. Update on the pathogenesis and treatment of systemic idiopathic arthritis. Curr. Opin. Pediatr. 2011; 23 (6): 640–646.; Bruck N., Schnabel A., Hedrich C. M. Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Clin. Immunol. 2015; 159 (1): 72–83.; Shimizu M., Nakagishi Y., Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013; 61 (2): 345–348.; Cazzola M., Ponchio L., De Benedetti F., Ravelli A., Rosti V., Beguin Y. et al. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood. 1996; 87: 4824–4830.; De Benedetti F., Massa M., Robbioni P., Ravelli A., Burgio G. R., Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1991; 34: 1158–1163.; Hartman J., Frishman W. H. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol. Rev. 2014; 22 (3): 147–151.; Ringold S., Weiss P. F., Beukelman T. Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications. Arthritis Care & Res. 2013; 65 (10): 1551–1563.; Vannucci G., Cantarini L., Giani T., Marrani E., Moretti D., Pagnini I., Simonini G., Cimaz R. Glucocorticoids in the management of systemic juvenile idiopathic arthritis. Paediatr Drugs. 2013; 15 (5): 343–349.; Валиева С. И., Алексеева Е. И., Акулова С. С., Бзарова Т. М., Денисова Р. В., Исаева К. Б., Слепцова Т. В., Митенко Е. В., Чистякова Е. Г., Фетисова А. Н., Семикина Е. Л. Эффективность и безопасность длительного применения ритуксимаба у пациентов с системным ювенильным идиопатическим артритом. Вопросы современной педиатрии. 2013; 12 (2): 89–100.; Pardeo M., Pires Marafon D., Insalaco A., Bracaglia C., Nicolai R., Messia V., De Benedetti F. Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience. J. Rheumatol. 2015; 42 (8): 1523–1527.; Yokota S., Tanaka T., Kishimoto T. Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis. Ther. Adv. Musculoskelet. Dis. 2012; 4 (6): 387–397.; Alexeeva E., Denisova R., Valieva S., Bzarova T., Isayeva K., Sleptsova T., Mitenko E. Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 2011; 9 (Suppl. 1): 202.; Каледа М. И., Никишина И. П. Лечение системного варианта ювенильного идиопатического артрита с применением генно-инженерных биологических препаратов в клинической практике. Педиатрия. 2015; 2: 116–124.; Brunner H. I., Ruperto N., Zuber Z., Keane C., Harari O., Kenwright A., Lu P., Cuttica R., Keltsev V., Xavier R. M., Calvo I., Niki shina I., Rubio-Perez N., Alexeeva E., Chasnyk V., Horneff G., Opoka-Winiarska V., Quartier P., Silva C. A., Silverman E., Spin dler A., Baildam E., Gamir M. L., Martin A., Rietschel C., Siri D., Smolewska E., Lovell D., Martini A., De Benedetti F. for the Paediatric Rheuma tology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, doubleblind withdrawal trial. Ann. Rheum. Dis. 2015; 74 (6): 1110–1117.; Балыкова Л. А., Краснопольская А. В., Корнилова Т. И., Широкова А. А. Проблема метаболических нарушений при ювенильных артритах у детей, проживающих на территории Республики Мордовия. Научно-практическая ревматология. 2014; (52) 5: 572–577.; DeWitt E. M., Kimura Y., Beukelman T., Nigrovic P. A., Onel K., Prahalad S., Schneider R., Stoll M. L., Angeles-Han S., Milojevic D., Schikler K. N., Vehe R. K., Weiss J. E., Weiss P., Ilowite N. T., Wallace C. A. Juvenile Idiopathic Arthritis Disease-specific Research Committee of Child-hood Arthritis Rheumatology and Research Alliance. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken). 2012; 64 (7): 1001–1010.; De Benedetti F., Brunner H. I., Ruperto N., Kenwright A., Wright S., Calvo I., Cuttica R., Ravelli A., Schneider R., Woo P., Wouters C., Xavier R., Zemel L., Baildam E., Burgos-Vargas R., Dolezalova P., Garay S. M., Merino R., Joos R., Grom A., Wulffraat N., Zuber Z., Zulian F., Lovell D., Martini A. PRINTO; PRCSG. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N. Engl. J. Med. 2012; 367: 2385–2395.; Alexeeva E., Denisova R., Valieva S., Bzarova T., Isayeva K., Sleptsova T., Chistyakova E., Fetisova A., Lomakina O. Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 2014; 12 (Suppl. 1): 62.; https://vsp.spr-journal.ru/jour/article/view/1513

  17. 17
  18. 18
  19. 19
  20. 20